Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

V.B.C. Biemans, A.E. van der Meulen-de Jong, C.J. van der Woude, M. Lowenberg, G. Dijkstra, B. Oldenburg, N.K.H. de Boer, S. van der Marel, A.G.L. Bodelier, J.M. Jansen, J.J.L. Haans, R. Theeuwen, D. de Jong, M.J. Pierik, F. Hoentjen, Dutch Initiative Crohn and Colitis

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)33-45
Number of pages13
JournalJournal of Crohn's & Colitis
Volume14
Issue number1
DOIs
Publication statusPublished - 1 Jan 2020

Keywords

  • anti-tnf
  • crohn's disease
  • efficacy
  • icc registry
  • induction
  • inflammatory-bowel-disease
  • maintenance therapy
  • outcomes
  • real-world experience
  • subcutaneous ustekinumab
  • ustekinumab
  • ANTI-TNF
  • EFFICACY
  • Ustekinumab
  • Crohn's disease
  • INDUCTION
  • MAINTENANCE THERAPY
  • INFLAMMATORY-BOWEL-DISEASE
  • SUBCUTANEOUS USTEKINUMAB
  • ICC Registry
  • OUTCOMES
  • REAL-WORLD EXPERIENCE

Cite this